Literature DB >> 29128662

Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist.

Damien Carignan1, Sabine Herblot2, Marie-Ève Laliberté-Gagné1, Marilène Bolduc1, Michel Duval2, Pierre Savard3, Denis Leclerc4.   

Abstract

Rod-shaped virus-like nanoparticles (VLNP) made of papaya mosaic virus (PapMV) coat proteins (CP) self-assembled around a single stranded RNA (ssRNA) were showed to be a TLR7 agonist. Their utilization as an immune modulator in cancer immunotherapy was shown to be promising. To establish a clinical relevance in human for PapMV VLNP, we showed that stimulation of human peripheral blood mononuclear cells (PBMC) with VLNP induces the secretion of interferon alpha (IFNα) and other pro-inflammatory cytokines and chemokines. Plasmacytoid dendritic cells (pDCs) were activated and secreted IFN-α upon VLNP exposure. Monocyte-derived dendritic cells upregulate maturation markers and produce IL-6 in response to PapMV VLNP stimulation, which suggests the activation of TLR8. Finally, when co-cultured with NK cells, PapMV induced pDCs promoted the NK cytolytic activity against cancer cells. These data obtained with primary human immune cells further strengthen the clinical relevance of PapMV VLNPs as a cancer immunotherapy agent.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer immunotherapy; Nanoparticles; Papaya mosaic virus; Plasmacytoid dendritic cells; TLR7; TLR8 adjuvant

Mesh:

Substances:

Year:  2017        PMID: 29128662     DOI: 10.1016/j.nano.2017.10.015

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  15 in total

1.  In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.

Authors:  Abner A Murray; Chao Wang; Steven Fiering; Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2018-05-25       Impact factor: 4.939

2.  Endosomal toll-like receptors play a key role in activation of primary human monocytes by cowpea mosaic virus.

Authors:  Marwah M Albakri; Frank A Veliz; Steven N Fiering; Nicole F Steinmetz; Scott F Sieg
Journal:  Immunology       Date:  2019-11-15       Impact factor: 7.397

Review 3.  Current approaches of nanomedicines in the market and various stage of clinical translation.

Authors:  Xiaoting Shan; Xiang Gong; Jie Li; Jingyuan Wen; Yaping Li; Zhiwen Zhang
Journal:  Acta Pharm Sin B       Date:  2022-03-01       Impact factor: 14.903

4.  Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.

Authors:  Chao Wang; Veronique Beiss; Nicole F Steinmetz
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

Review 5.  The pharmacology of plant virus nanoparticles.

Authors:  Christian Isalomboto Nkanga; Nicole F Steinmetz
Journal:  Virology       Date:  2021-01-28       Impact factor: 3.616

6.  Alfalfa mosaic virus nanoparticles-based in situ vaccination induces antitumor immune responses in breast cancer model.

Authors:  Mehdi Shahgolzari; Maghsoud Pazhouhandeh; Morteza Milani; Steven Fiering; Ahmad Yari Khosroushahi
Journal:  Nanomedicine (Lond)       Date:  2021-01-14       Impact factor: 5.307

Review 7.  Repurposing Plant Virus Nanoparticles.

Authors:  Kathleen L Hefferon
Journal:  Vaccines (Basel)       Date:  2018-02-14

Review 8.  Myeloid Cells during Viral Infections and Inflammation.

Authors:  Ashley A Stegelmeier; Jacob P van Vloten; Robert C Mould; Elaine M Klafuric; Jessica A Minott; Sarah K Wootton; Byram W Bridle; Khalil Karimi
Journal:  Viruses       Date:  2019-02-19       Impact factor: 5.048

9.  Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors.

Authors:  Chenkai Mao; Veronique Beiss; Jennifer Fields; Nicole F Steinmetz; Steven Fiering
Journal:  Biomaterials       Date:  2021-05-25       Impact factor: 12.479

Review 10.  Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.

Authors:  Christine E Boone; Lu Wang; Aayushma Gautam; Isabel G Newton; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.